| Dishman Carbogen Amcis Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540701 |
NSE Symbol : DCAL |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE385W01011 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 247.62 |
Market Cap(₹Cr) : 2,398.00 |
Face Value(₹) : 2.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 231.56 | 399.84 | 327.35 | 402.55 | 306.61 |
| Other Income | 84.52 | 32.98 | 63.05 | 52.16 | 60.39 |
| Stock Adjustments | 16.36 | -14.00 | -8.27 | -8.00 | 7.70 |
| Total Income | 332.44 | 418.82 | 382.13 | 446.71 | 374.70 |
| EXPENDITURE : | |||||
| Raw Materials | 55.67 | 117.01 | 107.70 | 163.35 | 107.11 |
| Power and Fuel Cost | 23.87 | 32.16 | 28.71 | 33.07 | 24.83 |
| Other Manufacturing Expenses | 20.96 | 21.69 | 27.94 | 31.21 | 22.57 |
| Selling and Administration Expenses | 52.50 | 50.59 | 46.30 | 52.54 | 46.03 |
| Miscellaneous Expenses | 2.97 | 2.45 | 13.14 | 22.49 | 2.21 |
| Employee Benefit Expenses | 86.63 | 90.15 | 91.54 | 86.13 | 79.04 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 89.84 | 104.77 | 66.80 | 57.92 | 92.91 |
| Interest | 86.52 | 70.40 | 68.19 | 57.92 | 37.23 |
| Gross Profit | 3.32 | 34.37 | -1.39 | 0.00 | 55.68 |
| Depreciation | 62.57 | 65.20 | 101.61 | 96.20 | 140.07 |
| Profit Before Tax | -59.25 | -30.83 | -103.00 | -96.20 | -84.39 |
| Current Tax | 0.00 | 0.00 | 11.06 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -20.85 | -20.96 | -37.65 | -37.33 | -52.84 |
| Reported Net Profit | -38.40 | -9.87 | -76.41 | -58.87 | -31.55 |
| Extraordinary Items | 1.13 | 1.31 | -1.02 | -2.79 | -0.79 |
| Adjusted Net Profit | -39.53 | -11.18 | -75.39 | -56.08 | -30.76 |
| Adjustment below Net Profit | 0.00 | 0.49 | -0.07 | 0.33 | 0.10 |
| Profit/Loss Balance carried down | -320.31 | -310.93 | -234.45 | -175.91 | -144.47 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -358.71 | -320.31 | -310.93 | -234.45 | -175.92 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -2.45 | -0.63 | -4.87 | -3.75 | -2.01 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 247.59 | 257.05 | 258.46 | 262.39 | 269.88 |
| Book Value(Adj)-Unit Curr | 247.59 | 257.05 | 258.46 | 262.39 | 269.88 |
